analysis. Das A. Journal of Psychiatric Research 2019; 108:7-23 . [Included randomized clinical trials (RCTs) compared interventions (Exercise therapy (ET), cognitive behavioral therapy (CBT) or antidepressant (AD) medications) for depression in heart failure patients. This meta-analysis is suggestive of therapeutic benefit of ET and (CBT) in comparison to usual standard of care in treating depression in HF patients. However, comparison among the three interventions was not conclusive.]
Contact the library for a copy of this article
Congenital heart anomalies and non-white ethnicity are among the factors associated with poor survival rates in people with Down syndrome. Heslop P. Evidence-Based Nursing 2019;22(1):17.
[The authors reported that people with Down syndrome lived approximately 28 years less than the general population. Those with the poorest survival rates were people with congenital heart anomalies, non-white ethnicity, more severe intellectual disabilities, low birth weight, additional medical conditions, feeding and mobility problems, and the children of younger mothers and parents with lower educational [There is evidence that implantable cardioverter-defibrillator (ICD) for primary prevention in people with an ischaemic cardiomyopathy improves survival rate. The evidence supporting this intervention in people with non-ischaemic cardiomyopathy is not as definitive, with the recently published DANISH trial finding no improvement in survival rate. A systematic review was needed to evaluate the benefits and harms of using ICDs for primary prevention in people with non-ischaemic cardiomyopathy.]
Interventions to reduce mortality from in-hospital cardiac arrest: a mixed-methods study. 
Hogan H. Health Services and Delivery Research

Guidelines
The following new guidance has recently been published:
Optimal timing of coronary angiography and revascularization in patients with NSTEACS UpToDate;2019. https://www.uptodate.com/contents/non-st-elevation-acute-coronary-syndromesrevascularization?sectionName=Timing&topicRef=8353&anchor=H73942117&source=see_l ink&mkt_tok=eyJpIjoiTXpNd01XRTVaV1ZtTURJdyIsInQiOiJSOGhjYnc2QVZEUVwvK0 5NYjFmUmFTNWJaYk1sRElEb3FHaEFJXC9NNDlcL1wvRHp1NnkrRGFTOVJyS3lQem VFN29zQ0pxN3pOV2twSk51ZjE1amJWaGtcL1lQZ3RneHVOZWdobkRzcmVRNXBUckF 5YUJnQkx3U09FNEQ2V3p4NFo3UVZjIn0%3D#H73942117 [Randomized trials of patients with non-ST elevation acute coronary syndromes (NSTEACS) have found that most patients at high risk for adverse cardiovascular events benefit from coronary angiography and possible percutaneous coronary intervention within 48 hours of diagnosis. In addition, there is some evidence that individuals at very high risk for adverse cardiovascular events benefit from earlier invasive evaluation] Available with an NHS OpenAthens password for eligible users
Reports
The following report(s) may be of interest:
Aspirin bleeding risk 'balances out' lower heart attack risk in 'worried well'. NHS Behind the Headlines; 2019. https://www.nhs.uk/news/medication/aspirin-bleeding-risk-balances-out-lower-heart-attackrisk-worried-well/ [In this study UK researchers reviewed all the current evidence on the subject. After pooling data, researchers estimated that for every 265 people who took aspirin, only 1 would benefit from preventing a heart attack or stroke. On the other hand, for every 210 people who took aspirin, 1 would experience a serious bleeding event.] Freely available online Aspirin did not prevent deaths or disability in healthy older adults. NIHR Dissemination Centre; 2018. https://discover.dc.nihr.ac.uk/content/signal-000696/aspirin-did-not-prevent-deaths-ordisability-in-healthy-older-adults [NIHR Signal. In the ASPREE trial, older adults with no apparent cardiovascular disease who took daily aspirin saw no benefit in terms of reducing the chance of dying or having dementia or disability. Instead, it slightly increased their mortality and bleeding risk -aspirin was associated with an excess of 1.6 deaths per 1,000 people per year. Half of these deaths were due to cancer.]
Freely available online
Blood pressure warnings about the 'keto diet' may not apply to humans. NHS Behind the Headlines; 2019. https://www.nhs.uk/news/food-and-diet/blood-pressure-warnings-about-keto-diet-may-notapply-humans/ [Researchers fed one group of rats a high-fat diet and another group a normal-fat diet. They found rats on the high-fat diet had an increase in blood pressure of around 20% compared with the rats on a normal-fat diet. But it's not accurate to describe the diet used in the study as a "keto diet", as it consisted mainly of lard and rodent feed and was higher calorie than the normal-fat diet used in comparison. This study tells us little about the potential effects of such a diet on humans.]
The best dose of aspirin for cardiovascular protection may depend on body weight. NIHR Dissemination Centre; 2018. https://discover.dc.nihr.ac.uk/content/signal-000699/the-best-dose-of-aspirin-forcardiovascular-protection-may-depend-on-body-weight [NIHR Signal. Low dose aspirin only appears to be effective at preventing stroke or heart attack for people weighing less than 70kg, while higher doses are better for people who weigh over 70kg.] Freely available online
